Saniona
14.03 SEK
-1.68 %
Less than 1K followers
SANION
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-1.68 %
-9.83 %
-46.45 %
-33.82 %
-11.54 %
+90.88 %
+127.45 %
-31.05 %
+258.24 %
Saniona is a biotechnology company focused on developing innovative treatments for neurological and psychiatric diseases. The company is researching new therapies that can improve patient outcomes and quality of life. The company operates globally with a primary presence in Europe and North America. Saniona was founded in 2011 and is headquartered in Denmark.
Read moreMarket cap
1.94B SEK
Turnover
10.26M SEK
Revenue
434.4M
EBIT %
62.39 %
P/E
6.35
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26/5
2026
Interim report Q1'26
27/5
2026
General meeting '26
27/8
2026
Interim report Q2'26
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types
Kallelse till årsstämma i Saniona AB
Interview with Saniona's CEO during SCF's 17th Capital Markets Day Life Science
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
